reports
- GlobalData Healthcare Department
Pfenex Inc (PFNX) - Financial Analysis Review
Pfenex Inc (PFNX) - Financial Analysis Review Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple sclerosis; PF708, a peptide product candidate to treat high-risk fracture patients; and others. GlobalData's Pfenex Inc (PFNX) - Financial Analysis Revi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.